Has Edward Loizides, MD received payments from drug or device companies?

Yes. Drug and device makers reported $228 in general payments to Edward Loizides, MD across 7 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Edward Loizides, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Edward Loizides, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Edward Loizides, MD

Urology · Bay Shore, NYNPI 1114950383

Payments from drug & device makers

$228in general payments, 2019–2025

Across 7 payments — averaging $32.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Janssen Products, LP$100
Urogen Pharma, Inc.$57
Endo Pharmaceuticals Inc.$39
Coloplast$20
KARL Storz Endoscopy-america$12

What the payments were for

Food & beverage$12856%
Education$10044%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Janssen Products, LP	1	$100
Urogen Pharma, Inc.	2	$57
Endo Pharmaceuticals Inc.	2	$39
Coloplast	1	$20
KARL Storz Endoscopy-america	1	$12

How this compares

$228 in reported general payments places this provider in the 15th percentile of 952 urology providers in New York.

See all urology providers in New York →

Medicare billing

Part B allowed, 2024

$409,765

Medicare patients

867

Services billed

30,483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
GemtesaVibegron	99	$60,569
ElmironPentosan Polysulfate Sodium	15	$34,795
Tamsulosin Hcl	808	$12,152
Cefpodoxime Proxetil	276	$11,503
MyrbetriqMirabegron	14	$11,185
Finasteride	495	$6,977
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	471	$5,379
Testosterone	20	$5,086
Potassium Citrate ErPotassium Citrate	42	$4,424
Estradiol	41	$3,680
Tolterodine Tartrate ErTolterodine Tartrate	13	$2,360
Dutasteride	54	$2,180
Bicalutamide	47	$1,870
Solifenacin Succinate	24	$1,491
Silodosin	11	$1,222

Paid to pharmacies, not to this prescriber.

Other urology in Bay Shore

Christopher PieczonkaSyracuse$31.2M
Guarionex DecastroNew York$5.7M
Mitchell EfrosGarden City$4.2M
James McKiernanNew York$4.1M
William HuangNew York$3.9M
Jed KaminetskyMiddle Village$3.5M
Evan GoldfischerPoughkeepsie$3.1M
Gennady BratslavskySyracuse$2.5M
Ashutosh TewariNew York$2.5M
Manish ViraNew Hyde Park$2.1M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →